Biotech News
GH Research Announces Novel Therapies Symposium Presentation and Posters at the 2025 ECNP Congress
investor.ghres.com2026-05-06 14:58 EST
DUBLIN, Oct. 09, 2025 (GLOBE NEWSWIRE) -- GH Research PLC (Nasdaq: GHRS), a clinical-stage biopharmaceutical company dedicated to transforming the lives of patients by developing a practice-changing treatment in depression, today announced the acceptance of a Novel Therapies Symposium Presentation